The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women

AIDS

Volumn 22, Issue 4, 2008, Pages 527-531

  Strickler, Howard D ^a   Howard, Andrea A ^a   Peters, Marion ^b   Fazzari, Melissa ^a   Yu, Herbert ^c   Augenbraun, Michael ^d   French, Audrey L ^e   Young, Mary ^f   Gange, Stephen ^g   Anastos, Kathryn ^a   Kovacs, Andrea ^h  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY   (United States)

^d MAIMONIDES MEDICAL CENTER   (United States)

^e Jr Hospital of Cook County   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

APRI; Aspartate aminotransferase to platelet ratio index; Hepatitis C virus (HCV); HIV; IGF; IGFBP 3; Liver disease

Indexed keywords

ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; CLARITHROMYCIN; DELAVIRDINE; EFAVIRENZ; FLUCONAZOLE; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; NEVIRAPINE; RIFABUTIN; RIFAMPICIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; VORICONAZOLE;

ALCOHOL CONSUMPTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; ASPARTATE AMINOTRANSFERASES; EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER CIRRHOSIS; MIDDLE AGED; UNITED STATES; VIREMIA;

EID: 39849099955     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f22cdf     Document Type: Article

References (15)

1. Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 1999; 29:1743-1751.
2. Bridle KR, Li L, O'Neill R, Britton RS, Bacon BR. Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells. J Lab Clin Med 2006; 147:234-241.
3. Gentilini A, Marra F, Gentilini P, Pinzani M. Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells. J Hepatol 2000; 32:227-234.
4. Gentilini A, Feliers D, Pinzani M, Woodruff K, Abboud S. Characterization and regulation of insulin-like growth factor binding proteins in human hepatic stellate cells. J Cell Physiol 1998; 174:240-250.
5. Stefano JT, Correa-Giannella ML, Ribeiro CM, Alves VF, Massarollo PB, Machado MC, Giannella-Neto D. Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C. World J Gastroenterol 2006; 12:3821-3828.
6. Mattera D, Capuano G, Colao A, Pivonello R, Manguso F, Puzziello A, D'Agostini L. Increased IGF-I: IGFBP-3 ratio in patients with hepatocellular carcinoma. Clin Endocrinol (Oxf) 2003; 59:699-706.
7. Assy N, Hochberg Z, Enat R, Baruch Y. Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis. Dig Dis Sci 1998; 43:1317-1321.
8. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9:117-125.
9. Al-Harthi L, Voris J, Du W, Wright D, Nowicki M, Frederick T, et al. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells. J Infect Dis 2006; 193:1202-1210.
10. Snyder N, Gajula L, Xiao SY, Grady J, Luxon B, Lau DT, et al. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol 2006; 40:535-542.
11. Macias J, Giron-Gonzalez JA, Gonzalez-Serrano M, Merino D, Cano P, Mira JA, et al. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple noninvasive indexes. Gut 2006; 55:409-414.
12. Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, et al. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 2005; 40:538-544.
13. Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, Promrat K, et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003; 124:97-104.
14. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363:1346-1353.
15. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Office of AIDS Research, National Institutes of Health, 2006. Available at: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed: October 2007.